Alerting colleagues in human medicine,
pediatric oncologist studied the issue and reported the same is true for children.
Not exact matches
Shannon Maude, MD, PhD, an assistant professor of Pediatrics and a
pediatric oncologist at CHOP, and Noelle Frey, MD, MSCE, an assistant professor of Medicine and an
oncologist at Penn's Abramson's Cancer Center, are co-first authors of the new
study.
Two
studies detailing the latest results of
pediatric trials of CTL019 for ALL will be presented by Shannon Maude, MD, PhD, an assistant professor of Pediatrics and a
pediatric oncologist at CHOP.
All four boys are alive and have improved between nine and 24 months following treatment, according to
study principal investigator Sung - Yun Pai, MD, a
pediatric hematologist -
oncologist from Dana - Farber / Boston Children's Cancer and Blood Disorders Center.